Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Journal of Cellular Biochemistry
|
April 23, 2016
Androgen Control in Prostate Cancer
Vasiliki Pelekanou, Elias Castanas
Breast Cancer Research : BCR
|
December 19, 2018
CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers
Vasiliki Pelekanou, Franz Villarroel-Espindola, Kurt A Schalper, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
November 14, 2017
Androgen Triggers the Pro-Migratory CXCL12/CXCR4 Axis in AR-Positive Breast Cancer Cell Lines: Underlying Mechanism and Possible Implications for the Use of Aromatase Inhibitors in Breast Cancer
Kalliopi Azariadis, Fotini Kiagiadaki, Vasiliki Pelekanou, et al.
JCO Precision Oncology
|
September 14, 2020
Immunological Differences Between Immune-Rich Estrogen Receptor-Positive and Immune-Rich Triple-Negative Breast Cancers
Tess O'Meara, Michal Marczyk, Tao Qing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 26, 2017
B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes
Mehmet Altan, Vasiliki Pelekanou, Kurt A Schalper, et al.
Journal of Leukocyte Biology
|
September 24, 2015
Estrogen anti-inflammatory activity on human monocytes is mediated through cross-talk between estrogen receptor ERα36 and GPR30/GPER1
Vasiliki Pelekanou, Marilena Kampa, Foteini Kiagiadaki, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
September 6, 2018
Ki67 reproducibility using digital image analysis: an inter-platform and inter-operator study
Balazs Acs, Vasiliki Pelekanou, Yalai Bai, et al.
Scientific Reports
|
October 19, 2019
Identification and Validation of a Novel Biologics Target in Triple Negative Breast Cancer
Vikram B Wali, Gauri A Patwardhan, Vasiliki Pelekanou, et al.
JAMA Oncology
|
November 13, 2015
Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer
Joseph McLaughlin, Gang Han, Kurt A Schalper, et al.
Breast Cancer Research : BCR
|
August 9, 2017
Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance
Vasiliki Pelekanou, Daniel E Carvajal-Hausdorf, Mehmet Altan, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Journal of Cellular Biochemistry
|
April 23, 2016
Androgen Control in Prostate Cancer
Vasiliki Pelekanou, Elias Castanas
Breast Cancer Research : BCR
|
December 19, 2018
CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers
Vasiliki Pelekanou, Franz Villarroel-Espindola, Kurt A Schalper, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
November 14, 2017
Androgen Triggers the Pro-Migratory CXCL12/CXCR4 Axis in AR-Positive Breast Cancer Cell Lines: Underlying Mechanism and Possible Implications for the Use of Aromatase Inhibitors in Breast Cancer
Kalliopi Azariadis, Fotini Kiagiadaki, Vasiliki Pelekanou, et al.
JCO Precision Oncology
|
September 14, 2020
Immunological Differences Between Immune-Rich Estrogen Receptor-Positive and Immune-Rich Triple-Negative Breast Cancers
Tess O'Meara, Michal Marczyk, Tao Qing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 26, 2017
B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes
Mehmet Altan, Vasiliki Pelekanou, Kurt A Schalper, et al.
Journal of Leukocyte Biology
|
September 24, 2015
Estrogen anti-inflammatory activity on human monocytes is mediated through cross-talk between estrogen receptor ERα36 and GPR30/GPER1
Vasiliki Pelekanou, Marilena Kampa, Foteini Kiagiadaki, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
September 6, 2018
Ki67 reproducibility using digital image analysis: an inter-platform and inter-operator study
Balazs Acs, Vasiliki Pelekanou, Yalai Bai, et al.
Scientific Reports
|
October 19, 2019
Identification and Validation of a Novel Biologics Target in Triple Negative Breast Cancer
Vikram B Wali, Gauri A Patwardhan, Vasiliki Pelekanou, et al.
JAMA Oncology
|
November 13, 2015
Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer
Joseph McLaughlin, Gang Han, Kurt A Schalper, et al.
Breast Cancer Research : BCR
|
August 9, 2017
Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance
Vasiliki Pelekanou, Daniel E Carvajal-Hausdorf, Mehmet Altan, et al.
Page
of 3